Approval · Notice of Compliance 8544 · 2007

REACTINE: Notice of Compliance 8544

Issued January 23, 2007

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 8544
Date: January 23, 2007
Company: Mcneil Consumer Healthcare
Product type: Nonprescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Manufacturer name change
Therapeutic class: Histamine h1 receptor antagonist

Products in this notice

Brand	DIN	Status today
REACTINE	02238337	Marketed
REACTINE	02223546	Marketed
REACTINE	02223554	Marketed

Medicinal ingredients

CETIRIZINE HYDROCHLORIDE 5 MG per 5ML
CETIRIZINE HYDROCHLORIDE 5 MG per TAB
CETIRIZINE HYDROCHLORIDE 10 MG per TAB